Talk:Afoxolaner

This is the talk page for discussing improvements to the Afoxolaner article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Veterinary medicine Mid‑importance

	This article is within the scope of WikiProject Veterinary medicine, a collaborative effort to improve the coverage of Veterinary medicine on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Veterinary medicineWikipedia:WikiProject Veterinary medicineTemplate:WikiProject Veterinary medicineVeterinary medicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Afoxolaner.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Elimination half-life is NOT 14 hours[edit]

Wikipedia now says:

Elimination half-life: 14 hours

This can't be right, not even close. The drug is given every 30 days to dogs.

For toxicology what is important is elimination half-life in BLOOD. This can't be 14 hours, because afoxolaner binds tightly to plasma proteins. How are plasma proteins eliminated and what is half-life of plasma proteins?

For efficacy against Ticks what is important is elimnation half-life in SKIN? Which is likely longer than in blood.

91.159.188.106 (talk) 13:00, 15 March 2024 (UTC)[reply]

Legal status is incorrect, as FrontPro is OTC drug in Europe[edit]

Wikipedia claims:

Legal status CA: ℞-only US: ℞-only EU: Rx-only OTC (RU)

With so many errors in this Wikipedia article, can we trust even other information on this page?

For example Frontpro 136mg is over-the-counter drug for 25-50kg dogs in European Union. No precription is required, sold at pharmacy for example in Finland.

Afoxolaner was a prescription-only drug and prescription-only brands of this drug still exist.

91.159.188.106 (talk) 12:58, 15 March 2024 (UTC)[reply]

Neurological side effect for Dogs is a major concern[edit]

Neurological side effect for Dogs is much more common than vet drug manufacturers claim in product labels.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738705/ 2020 Nov.

A veterinarian and pet owner survey (Project Jake) examined the use and safety of isoxazoline parasiticides given to dogs.

58% (1594) had been treated with some parasiticide for flea control, and of those that received a parasiticide, the majority, or 83% (1,325), received an isooxazoline. When any flea treatment was given, AE were reported for 66.6% of respondents, with no apparent AE noted for 36.1%.

Survey responders did not indicate the Recovery Status from neurological effects. However, several isolated reports (private communications with the authors of which 3 are veterinarians have indicated extended long‐term neurologic signs with InComplete amelioration).

With respect to pet age, serious AE showed death reported in about 60% of dogs older than 5 years with seizures in more than 50% of dogs older than 5 years.

The most serious AE as stated in the EMA cumulative reports were observed at 0–24 hr after the first dose, and then again after the second and third doses.

91.159.188.106 (talk) 15:51, 15 March 2024 (UTC)[reply]